Barry E Greene
CIK 1291963 · President and CEO · last filed 2026-10-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ALNY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
85 WELLS AVENUE, 2ND FLOOR
NEWTON, MA 02459
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTY | Director | — | — | — | $0 | 1 | 2026-10-19 |
| DYN | Director | — | $16.10 | — | $0 | 1 | 2026-06-23 |
| KPTI | Director | 16,415 | $0.02 | $286 | $87.9K | 16 | 2026-05-26 |
| Sage Therapeutics, Inc. (SAGE) Delisted | President and CEO | 0 | $8.68 | $0 | $2.02M | 13 | 2025-07-31 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | Director | 11 | $0.66 | $7 | -$290.2K | 20 | 2021-06-04 |
| ALNY | President | 68,570 | $148.09 | $10.15M | -$60.74M | 55 | 2020-09-11 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 51,254 | $8.16 | $418.2K | $0 | 2 | 2012-11-07 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| ALNY | Direct | 65,412 | 95.4% | 2020-09-11 |
| by Managed Account | 3,003 | 4.4% | 2020-09-11 | |
| by Dependent | 155 | 0.2% | 2020-09-11 | |
| GRAT were gifted to a non-dependent child by Trust |
0 | 0.0% | 2020-09-11 | |
| Total | 68,570 | |||
| RGLS | Alnylam Pharmaceuticals Inc See footnote |
51,254 | 100.0% | 2012-10-11 |
| Total | 51,254 |
Recent Filings · Page 3 of 11
108 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-21 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2021-01-06 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-05 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-09-11 | ALNY | Mixed | −155 | -$5.08M | EDGAR |
| 2020-08-11 | ALNY | Exer (M) | +4,931 | $349.9K | EDGAR |
| 2020-07-09 | ALNY | Mixed | — | -$3.36M | EDGAR |
| 2020-06-17 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-26 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2020-05-07 | ALNY | Mixed | — | -$3.14M | EDGAR |
| 2020-04-09 | ALNY | Mixed | +3,754 | -$174.3K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).